Immuno-SPECT imaging of aberrant p53 expression in pancreatic ductal adenocarcinoma
<p>Pancreatic ductal adenocarcinoma (PDAC) is a notoriously ferocious malignancy arising from the head of the pancreas, with aggressive biology and early-onset metastases. PDAC develop and progress asymptomatically with over 80% of the patients presenting for diagnosis with inoperable metastat...
Váldodahkki: | Alakonya, H |
---|---|
Eará dahkkit: | Cornelissen, B |
Materiálatiipa: | Oahppočájánas |
Giella: | English |
Almmustuhtton: |
2023
|
Geahča maid
-
Imaging p53 in pancreatic ductal adenocarcinoma
Dahkki: Koustoulidou, S
Almmustuhtton: (2017) -
Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
Dahkki: Koustoulidou, S, et al.
Almmustuhtton: (2016) -
Immuno-phenotypes of Pancreatic Ductal Adenocarcinoma: Metaanalysis of transcriptional subtypes
Dahkki: De Santiago, I, et al.
Almmustuhtton: (2018) -
Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma
Dahkki: Venugopal Gunda, et al.
Almmustuhtton: (2022-01-01) -
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Dahkki: Yunzhen Qian, et al.
Almmustuhtton: (2022-06-01)